1. Xu C, Ruan X*, Mueck AO.Progress in genome-wide association studies of age at natural menopause..Reprod Biomed Online.2022.Online ahead of print..00828-8.SCI |
2. 李妍秋,谷牧青,阮祥燕*.卵巢组织冻存移植的安全性研究进展.中国医刊.2022.57(11).1179-1183.核心期刊 |
3. 许新,阮祥燕*,鞠蕊,杨瑜,程姣姣,王志坤,Alfred O. Mueck.中国女性轻度认知障碍的影响因素及其与绝经症状的关系.首都医科大学学报.2022.43(03). 369-374.核心期刊 |
4. 赵越*,阮祥燕,谷牧青,许新,程姣姣.PGRMC1在激素治疗中促进乳腺癌细胞增殖的机制研究.中国癌症防治杂志.2022.14(04).378-384.核心期刊 |
5. 阮祥燕*,中国人体健康科技促进会生育力保护与保存专业委员会,国际妇科内分泌学会中国妇科内分泌学分会.妊娠期乳腺癌患者生育力保护专家共识.中国临床医生杂志.2022.50(07).772-777.核心期刊 |
6. Ruan X*,Committee of Fertility Protection and Preservation of China Association for the Promotion of Health Science and Technology Chinese Society of Gynecological Endocrinology affiliated to the International Society of Gynecological Endocrinology .Expert consensus on fertility preservation in patients with breast cancer occurring during pregnancy.Gynecol Endocrinol.2022.38(10).797-802.SCI |
7. Xu X, Ruan X*, Ju R, Wang Z, Yang Y, Cheng J, Gu M, Mueck AO..Progesterone Receptor Membrane Component-1 May Promote Survival of Human Brain Microvascular Endothelial Cells in Alzheimer's Disease.Am J Alzheimers Dis Other Demen.2022.37.1-9.SCI |
8. Jin L, Ruan X*, Jin J, Wang Y, Zhang Y, Zhou Q, Lu D, Mueck AO..Infertile women with endometriosis possess differences in cytokine levels in various tissues..Gynecol Endocrinol..2022.38(6).523-527.SCI |
9. Cheng J, Ruan X, Li Y, Du J, Jin F, Gu M, Zhou Q, Xu X, Yang Y, Wang H, Mueck AO. .Effects of hypoxia-preconditioned HucMSCs on neovascularization and follicle survival in frozen/thawed human ovarian cortex transplanted to immunodeficient mice..Stem Cell Res Ther.2022.13(1).474.SCI |
10. Min M, Ruan X, Wang H, Cheng J, Luo S, Xu Z, Li M, Mueck AO..Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients. .Gynecol Endocrinol. .2022.38(8).676-680.SCI |
11. Gu M, Ruan X, Li Y, Li T, Yin C, Mueck AO. .Effect on the cardiovascular independent risk factor lipoprotein(a) in overweight or obese PCOS patients with ethinyl-estradiol/drospirenone alone or plus orlistat..Gynecol Endocrinol..2022.38(7).598-602.SCI |
12. 阮祥燕*,程姣姣,杜娟,谷牧青.卵巢组织冷冻保存.山东大学学报(医学版).2022.60(09).24-30.核心期刊 |
13. 杨瑜,阮祥燕*.抗苗勒管激素暴露对女性及其子代健康影响的研究进展.中国临床医生杂志.2022.50(09).1037-1040.核心期刊 |
14. 阮祥燕*, 中国人体健康科技促进会生育力保护与保存专业委员会,国际妇科内分泌学会中国妇科内分泌学分会,首都医科大学附属北京妇产医院/北京妇幼保健院妇科内分泌科.造血干细胞移植女童患者生育力保护中国专家共识.中国临床医生杂志.2022.50(09).1027-1032.核心期刊 |
15. 程姣姣,阮祥燕*,杜娟,谷牧青.未成熟卵母细胞体外成熟在生育力保护中的应用进展.首都医科大学学报.2022.43(03).329-335.核心期刊 |
16. Ruan X..Expert consensus on fertility preservation in hematopoietic stem cell transplantation in girls in China.Gynecol Endocrinol. .2022.20.1-6.SCI |
17. Xu Z, Ruan X*, Xu X, Yang Y, Cheng J, Luo S, Min M, Li M, Zhang L, Ju R, Jin F, Mueck AO..Efficacy and safety of Zi Gui Nv Zhen® capsules used in TCM for fertility preservation in patients with diminished ovarian reserve..Gynecol Endocrinol..2022.38(1).73-77.SCI |
18. 赵越,阮祥燕*,程姣姣,谷牧青,许新,王月姣.乳腺癌中PGRMC1表达与临床病理参数的相关性.首都医科大学学报.2022.43(03).350-356.核心期刊 |
19. Ruan X*, Du J, Lu D, Duan W, Jin F, Kong W, Wu Y, Dai Y, Yan S, Yin C, Li Y, Cheng J, Jia C, Liu X, Wu Q, Gu M, Ju R, Xu X, Yang Y, Jin J, Korell M, Montag M, Liebenthron J, Mueck AO. .First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency.Climacteric.2022.25(4).421-424.SCI |
20. Li M, Ruan X, Ju R, Min M, Xu Z, Luo S, Wang H, Mueck AO..Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?.Gynecol Endocrinol.2022.38(2).148-152.SCI |
21. 金凤羽,阮祥燕*,秦爽,许新,杨瑜,谷牧青,李妍秋,杜娟,程姣姣,尹晓丹.定坤丹治疗子宫内膜薄型不孕的临床效果.首都医科大学学报.2022.43(03).364-368.核心期刊 |
22. 赵越,阮祥燕*.PGRMC1在激素补充治疗中对乳腺癌增殖风险及机制的研究进展.医学综述.2022.28(06).1097-1102.核心期刊 |
23. 鞠蕊,阮祥燕*,代荫梅,白勇涛,杨瑜,许新,程姣姣,杨幸子,施琰红,孙艳华,李瑞玲.女性性功能障碍的影响因素研究.首都医科大学学报.2022.43(03).357-363.核心期刊 |
24. Xu Z, Ruan X*, Xu X, Yang Y, Cheng J, Luo S, Min M, Li M, Zhang L, Ju R, Jin F, Mueck AO..Efficacy and safety of Zi Gui Nv Zhen® capsules used in TCM for fertility preservation in patients with diminished ovarian reserve..Gynecol Endocrinol .2022.38(1).73-77.SCI |
25. Li M, Ruan X*, Ju R, Min M, Xu Z, Luo S, Wang H, Mueck AO..Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?.Gynecol Endocrinol.2022.38(2).148-152.SCI |
26. Zhang L, Ruan X*, Cui Y, Gu M, Mueck AO..Menopausal symptoms among Chinese peri- and postmenopausal women: a large prospective single-center cohort study..Gynecol Endocrinol..2021.37(2).185-189..SCI |
27. Cheng J, Ruan X*, Zhou Q, Li Y, Du J, Jin F, Wang H, Gu M, Mueck AO..How much total ovarian tissue can be removed without compromising ovarian function? An animal study..Gynecol Endocrinol..2021.37(3).240-245.SCI |
28. 阮祥燕*,杜娟,卢丹,段微,金凤羽,孔为民,吴玉梅,代荫梅,严松彪,阴赪宏,李扬璐,程姣姣,贾婵维,刘晓巍,吴青青,谷牧青,鞠蕊,许新,杨瑜,金婧,Matthias Korell,Markus Montag,Jana Liebenthron,Alfred O.Mueck.中国自体卵巢组织冻存移植后成功妊娠首例报道.中国临床医生杂志.2021.49(03).375-378.核心期刊 |
29. 田玄玄,阮祥燕*.多囊卵巢综合征与自身免疫性甲状腺疾病的相关性研究进展.国际医药卫生导报.2021.27(21).3308-3313.核心期刊 |
30. Cheng J, Ruan X, Zhou Q, Li Y, Du J, Jin F, Gu M, Mueck AO..Long-time low- temperature transportation of human ovarian tissue before cryopreservation..Reprod Biomed Online..2021.43(2).172-183.SCI |
31. Cai G, Wang Y, Houda T, Yang C, Wang L, Gu M, Mueck A, Croteau S, Ruan X, Hardy P..MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast epithelial MCF10A cells through the PGRMC1/EGFR-PI3K/Akt/mTOR signaling pathway..Transl Oncol..2021.14(6).101068.SCI |
32. Cheng J, Ruan X*, Zhou Q, Li Y, Du J, Jin F, Gu M, Mueck AO..Long-time low-temperature transportation of human ovarian tissue before cryopreservation.Reprod Biomed Online .2021.43(2).172-183.SCI |
33. Tian X, Ruan X*, Du J, Wang J, Yin D, Cheng J, Ju R, Mueck AO.Sexual Function in Chinese Women with Polycystic Ovary Syndrome and Correlation with Clinical and Biochemical Characteristics..Reprod Sci .2021.28(11).3181-3192..SCI |
34. Ju R, Ruan X*, Xu X, Yang Y, Cheng J, Zhang L, Wang B, Qin S, Dou Z, Mueck AO..Importance of active and passive smoking as one of the risk factors for female sexual dysfunction in Chinese women.Gynecol Endocrinol.2021.37(6).541-545.SCI |
35. Cheng J, Ruan X*, Du J, Jin F, Li Y, Liu X, Wang H, Gu M, Mueck AO..Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report.J Ovarian Res.2021.14(1).176.SCI |
36. 中国老年学和老年医学学会骨质疏松分会妇产科专家委员会与围绝经期骨质疏松防控培训部(阮祥燕*).围绝经期和绝经后妇女骨质疏松防治专家共识.中国临床医生杂志.2020.48(8).903-907.核心期刊 |
37. Genazzani A, Panay N, Simoncini T, Depypere H, Mueck A, Egarter C, Biglia N, Fait T, Birkhaeuser M, Skouby SO, Brincat M, Goldstein S, Ruan X, Celis-Gonzales C, Palacios S.Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptoms..Gynecol Endocrinol.2020.36(3).190-196.SCI |
38. 阮祥燕*,张凌燕,谷牧青,Alfred O.Mueck.绝经激素治疗与乳腺癌风险.中国实用妇科与产科杂志.2020.36(03).212-217.核心期刊 |
39. 王月姣,阮祥燕*,谷牧青,蔡桂举,李雪,张凌燕,Alfred O.Mueck.他莫昔芬治疗乳腺癌异种移植瘤裸鼠子宫病理改变.首都医科大学学报.2019.40(04).539-543.核心期刊 |
40. 赵越,阮祥燕*.间充质干细胞用于卵巢早衰患者生殖力保护的研究进展.中国临床医生杂志.2019.47(07).771-774.核心期刊 |
41. 谷牧青,贾婵维,阮祥燕.孕激素维持早期妊娠及防止流产的临床研究进展.中国临床医生杂志.2019.47(07).775-776.核心期刊 |
42. 杜娟,马飞,阮祥燕.乳腺癌患者生育力保护的研究进展.中国临床医生杂志.2019.47(07).769-771.核心期刊 |
43. 阮祥燕*,程姣姣,杜娟,金凤羽,李扬璐,Matthias Korell,Thomas Rabe,Alfred O.Mueck.卵巢组织冻存与移植对宫颈癌患者卵巢内分泌功能的影响.中国临床医生杂志.2019.47(07).759-762+754.核心期刊 |
44. 李雪,阮祥燕*,谷牧青,蔡桂举,赵越,Alfred O.Mueck.孕激素受体膜组分1促进雌孕激素诱导的乳腺癌细胞增生的研究——雌二醇与周期序贯及连续联合比较.首都医科大学学报.2019.40(02).237-243.核心期刊 |
45. 程姣姣,阮祥燕*,周琦,李扬璐,杜娟,金凤羽,谷牧青,Alfred O.Mueck.大鼠卵巢组织体积对其动情周期及体质量的影响.首都医科大学学报.2019.40(04).554-559.核心期刊 |
46. 张凌燕,阮祥燕*,蔡桂举,谷牧青,Alfred O.Mueck.他莫昔芬治疗转染孕激素受体膜组分1乳腺癌裸鼠模型对乳腺肿瘤组织Ki-67表达的影响.首都医科大学学报.2019.40(04).533-538.核心期刊 |
47. 赵越,阮祥燕*,王凤春,李扬璐,程姣姣,Alfred O.Mueck.低氧预处理人脐带间充质干细胞治疗早发性卵巢功能不全小鼠的效果研究.首都医科大学学报.2019.40(04).533-538.核心期刊 |
48. 闵敏,阮祥燕*,赵越,王虎生,程姣姣,罗穗豫,许仲婷,李萌,张露平,王月姣,Alfred O.Mueck.奥利司他综合干预对超重或肥胖型PCOS患者雄激素及糖脂代谢的影响.首都医科大学学报.2019.40(04).572-577.核心期刊 |
49. Wang Husheng,Ruan Xiangyan*,Li Yanglu,Cheng Jiaojiao,Mueck Alfred O.Oxidative stress indicators in Chinese women with PCOS and correlation with features of metabolic syndrome and dependency on lipid patterns.Archives of gynecology and obstetrics.2019.300(5).1413-1421.SCI |
50. Mueck AO, Ruan XY.Will estradiol/progesterone capsules for oral use become the best choice for menopausal hormone therapy.Climacteric : the journal of the International Menopause Society.2019.22. 535-537.SCI |
51. Ruan XY, Mueck AO, Beer AM.Cimicifuga racemosaBenefit-risk profile of black cohosh (isopropanolic extract) with and without St John's wort in breast cancer patients..Climacteric : the journal of the International Menopause Society.2019.22.339-347.SCI |
52. Muqing Gu, Lijuan Wang, Chun Yang, Xue Li, Chanwei Jia, Stephane Croteau, Xiangyan Ruan⁎, Pierre Hardy⁎ .Micro-RNA-181a suppresses progestin-promoted breast cancer cell growth.Maturitas.2018.114.60-66.SCI |
53. Jinghua Song,Xiangyan Ruan,Muqing Gu,Lijuan Wang,Husheng Wang,Alfred O. Mueck.Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.Gynecol Endocrinol .2018.34(5).413-417.SCI |
54. Yanglu Li,Xiangyan Ruan*, Husheng Wang,Xue Li,Guiju Cai,Juan Du,Lijuan Wang,Yue Zhao, Alfred O.Mueck.Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.fertility and sterility.2018.109(4).720-727.SCI |
55. 金婧,阮祥燕*,华琳,李杨璐,王利娟,赵越,王虎生.多囊卵巢综合征合并卵巢储备功能低下患者的发生现状.生殖医学杂志.2018.27(2).103-107.核心期刊 |
56. Lanrong Luo, Xiangyan Ruan*, Changdong Li, Suwen Chen, Qiaofei Hu & Alfred O. Mueck.Early clinical features and risk factors for cesarean scar pregnancy: a retrospective case-control study.Gynecological Endocrinology.2018.15.1-5.SCI |
57. 程姣姣,阮祥燕*,李杨璐,杜娟,王虎生,Alfred O.Mueck.北京及周边地区早发性卵巢功能不全的病因学研究.首都医科大学学报.2018.39(4).494-498.核心期刊 |
58. 李萌,阮祥燕*.多囊卵巢综合征的诊断、治疗与管理.中国医刊.2018.53(5).465-468.核心期刊 |
59. 王利娟,阮祥燕∗,赵越 .PGRMC1在乳腺癌组织中的表达及其与临床病理特征的相关性.首都医科大学学报.2018.39(2).272-276.核心期刊 |
60. 杜娟,阮祥燕*,Alfred O.Mueck.口服避孕药对多囊卵巢综合征患者性功能的影响.首都医科大学学报.2018.39(4).505-511.核心期刊 |
61. 张颖,阮祥燕*,蔡桂举,苏雅洁,李娜,Alfred O.Mueck.不同激素受体作为乳腺癌预后标志物的研究进展.首都医科大学学报.2018.39(4).479-485.核心期刊 |
62. Zhao Y, Ruan X*, Mueck AO..Letrozole combined with low dose highly purified HMG for ovulation induction in clomiphene citrate-resistant infertile Chinese women with polycystic ovary syndrome: a prospective study.Gynecol Endocrinol.2017.28.1-5.SCI |
63. Jin J, Ruan X*, Hua L, Tian X, Li Y, Wang L, Mueck AO..Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.Gynecol Endocrinol.2017.17.1-4.SCI |
64. Yin D, Ruan X*, Tian X, Du J, Zhao Y, Cui Y, Li Y, Mueck AO..The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.Gynecol Endocrinol.2017.33(4).332-335.SCI |
65. Sun Y , Ruan X , Mueck AO .Dependency of cardiovascular risk on reproductive stages and on age among middle-aged Chinese women.Climacteric.2017.20(5).484-490.SCI |
66. 王利娟,杨春,谷牧青,Pierre Hardy,阮祥燕,Alfred O.Mueck.受孕激素调节的microRNAs与乳腺癌的关系 .首都医科大学学报.2017.38(4).521-525.核心期刊 |
67. 李扬璐,阮祥燕,Alfred O.Mueck.人卵巢组织冻存与移植研究进展.首都医科大学学报.2017.38(04).485-491.核心期刊 |
68. 殷冬梅,阮祥燕,赵越,Alfred O.Mueck.北京地区多囊卵巢综合征病人内分泌代谢特征分析.首都医科大学学报.2017.38(04).498-503.核心期刊 |
69. 王娟,阮祥燕,金凤羽.二甲双胍联合辛伐他汀治疗多囊卵巢综合征的临床疗效.临床与病理杂志.2017.37(05).992-995.核心期刊 |
70. 王虎生,阮祥燕,李雪,赵越,李扬璐,谷牧青,杜娟,宋菁华,金凤羽,Alfred O.Mueck.抗苗勒管激素与抑制素B对多囊卵巢综合征的临床预测价值.首都医科大学学报.2017.38(04).492-497.核心期刊 |
71. 谷牧青,杨春,王利娟,Pierre Hardy,贾婵维,阮祥燕.miR-181a与乳腺癌关系的研究进展 .首都医科大学学报.2017.38(4).526-529.核心期刊 |
72. 金婧,阮祥燕,华琳,田玄玄,李杨璐,王利娟,赵越,Alfred O.Mueck.多囊卵巢综合征合并卵巢储备功能低下病人的内分泌特征.首都医科大学学报.2017.38(04).515-520.核心期刊 |
73. 金凤羽,阮祥燕,Alfred O.Mueck,刘玉兰,杜娟.北京及周边地区围绝经期女性性功能现状调查分析.首都医科大学学报.2017.38(04).509-514.核心期刊 |
74. 李雪,阮祥燕,王虎生,李扬璐,赵越,谷牧青,杜娟,宋菁华,金凤羽,Alfred O.Mueck.原发性卵巢功能不全对病人糖脂代谢及生物化学指标的影响.首都医科大学学报.2017.38(04).504-508.核心期刊 |
75. 刘玉兰,阮祥燕*.综合护理干预对围绝经期和绝经后期女性激素补充治疗的影响 .中国医刊.2017.52(7).77-80. |
76. Ruan X, Kubba A, Aguilar A, Mueck AO.Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.Eur J Contracept Reprod Health Care .2017.183-190.22(3).SCI |
77. 王利娟,阮祥燕,崔亚美,赵越,杜娟,李扬璐,易迎春,Alfred O.Mueck. . 多囊卵巢综合征不同表型的血清抗苗勒管激素水平特征的分析.首都医科大学学报.2016.(04).444-448.核心期刊 |
78. 赵越,阮祥燕,李扬璐,杜娟,Alfred O.Mueck.. 来曲唑联合高纯度尿促性素治疗克罗米芬耐药的多囊卵巢综合征不孕患者的临床研究.首都医科大学学报.2016.(04).431-436.核心期刊 |
79. 李扬璐,阮祥燕,赵越,杜娟,王利娟,崔亚美,Alfred O.Mueck..达英-35对多囊卵巢综合征患者糖脂代谢的影响. 首都医科大学学报.2016.(04).424-430.核心期刊 |
80. 李扬璐,阮祥燕,赵越,杜娟,王利娟,崔亚美,Alfred O.Mueck..百令胶囊对多囊卵巢综合征代谢指标的影响.首都医科大学学报.2016.(04).437-443.核心期刊 |
81. 阮祥燕,谷牧青..乳腺癌可否采用绝经激素治疗. 中国实用妇科与产科杂志.2016.(01).85-89.核心期刊 |
82. Zhao Y, Ruan X*, Mueck AO..Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes.Gynecol Endocrinol.2016.32(2).151-156.SCI |
83. Zhang Y, Ruan X*, Willibald M, Seeger H, Fehm T, Neubauer H, Mueck AO..May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?.Gynecol Endocrinol.2016.32(1).58-60.SCI |
84. Du J, Ruan X*, Gu M, Bitzer J, Mueck AO..Prevalence of and risk factors for sexual dysfunction in young Chinese women according to the Female Sexual Function Index: an internet-based survey.Eur J Contracept Reprod Health Care.2016.21(3).259-263.SCI |
85. Ruan X, Cui Y, Du J, Jin F, Mueck AO..Prevalence of climacteric symptoms comparing perimenopausal and postmenopausal Chinese women.J Psychosom Obstet Gynaecol.2016.21.1-9.SCI |
86. 阮祥燕,宋菁华..月经过多的病因与诊治. 实用妇产科杂志.2016.(12).883-885.核心期刊 |
87. 孙艳格,阮祥燕,Alfred O.Mueck..围绝经期及绝经后妇女心血管疾病危险因素的变化.首都医科大学学报.2016.(04).413-417.核心期刊 |
88. 阮祥燕,杜娟,卢丹,孔为民,代荫梅,阴赪宏,严松彪,金凤羽,金婧,崔亚美,费秀珍,Matthias Korell,Jana Liebenthron,Markus Montag,Alfred O.Mueck. .中国首例冻存卵巢组织移植报告.首都医科大学学报.2016.(06).840-842.核心期刊 |
89. 李扬璐,阮祥燕,Alfred O.Mueck..多囊卵巢综合征对妊娠结局的影响研究进展.首都医科大学学报.2016.(04).449-453.核心期刊 |
90. 阮祥燕,宋菁华. .妇科内分泌疾病与复发性流产.实用妇产科杂志.2016.(02).81-83.核心期刊 |
91. Cui Y, Ruan X*, Jin J, Jin F, Brucker S, Mueck AO..The pattern of lipids and lipoproteins during the menopausal transition in Chinese women.Climacteric.2016.29.1-7.SCI |
92. Ruan X, Seeger H, Wallwiener D, Huober J, Mueck AO..The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.Arch Gynecol Obstet.2015.291(5).1141-1146.SCI |
93. Ruan X, Mueck AO..Oral contraception for women of middle age..maturitas.2015.82(3).266-270.SCI |
94. Ruan X, Mueck AO..Impact of smoking on estrogenic efficacy.Climacteric.2015.18.38-46.SCI |
95. Liu S, Ruan X*, Schultz S, Neubauer H, Fehm T, Seeger H, Mueck AO..Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: Comparison of four oestrogens.Europ J Contraception and Reprod Health .2015.20.29-35.SCI |
96. Wu H, Ruan X*, Jin J, Mueck AO..Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes. Gynecol Endocrinology.2015.31(7).548-551.SCI |
97. Xiangyan Ruan, Alfred.O. Mueck..Systemic progesterone therapy—Oral, vaginal, injections and even transdermal?.Maturitas.2014.79(2014).248-255.SCI |
98. Xuanxuan Tian, Xiangyan Ruan*, Alfred O. Mueck, Diethelm Wallwiener, Juan Wang, Shunyu Liu, Dongmei Yin, Yongjun Lu, Ying Zhang, and Hongqin Wu..Serum anti-Mu¨llerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.Gynecological Endocrinology.2014.30(11).836-839.SCI |
99. Ruan X, Mueck AO..EDITORIAL:Chinese Obstetrician Gynecologists still need more education in Menopausal Hormone Therapy.Menopause.2014.21(11).1170-1172.SCI |
100. RUAN.X, NEUBAUER.H,SEEGER H, MUECK A.O..Breast cancer and progestogens: could certain cell components predict the risk? .Giorn.It.Ost.Gin..2012.XXXIV(l).68-73.SCI |
101. 杨树琳,梁秀兰,阮祥燕*.雌二醇对去势SD大鼠糖脂代谢影响的研究.中国全科医学.2012.15(2C).651-653..核心期刊 |
102. Ruan X, Seeger H, Mueck AO..The pharmacology of nomegestrol acetate..Maturitas .2012.7(4).345-353.SCI |
103. 阮祥燕,张俊丽,田玄玄.乳腺癌风险的研究.中国妇幼健康研究.2012.23(1).127-131.核心期刊 |
104. Ruan X, Seeger H, Mueck AO.. The pharmacology of dienogest..Maturitas .2012.71(4).337-344.SCI |
105. MUECK A.O,RUAN.X, SEEGER H ..Are estrogen metabolites carcinogenic?.Giorn.It.Ost.Gin..2012.XXXIV(l).61-67.SCI |
106. Ruan X, Neubauer H, Seeger H, Fehm T, Mueck AO..Possible mechanisms for the observed increased breast cancer risk using norethisterone in hormone therapy..Maturitas.2012.71 (1) .S44-S45.SCI |
107. Ruan X, Neubauer H, Seeger H, Fehm T, Mueck AO..Effect of continuous vs sequential estradiol/progestogen on the proliferation of human breast cancer cells overexpressing PGRMC1.. Maturitas.2012.71 (1).S21.SCI |
108. 1. Ruan X, Schneck H, Schultz S, Fehm T, Cahill MA, Seeger H, Chen R, Yu Q, Mueck AO, Neubauer H. .Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells. .Gynecol Endocrinol..2012.28(11).863-866.SCI |
109. X. Ruan, H. Neubauer, Y. Yang..Progestogen and membrane-initiated effects on the proliferation of human breast cancer cells. .Climacteric..2012.15.467-472.SCI |
110. 马丽灵,阮祥燕*.妈富隆治疗围绝经期功能失调性子宫出血59例分析.现代中西医结合杂志.2011.20(35).4504-4508. |
111. Mueck AO, Ruan X..Benefits and risks during HRT – main safety issue breast cancer.Horm Mol Biol Clin Invest.2011.5(2).105-116.SCI |
112. Mueck AO, Seeger H, Ruan X.Oral contraception and risk of endometrial cancer.J Contraception.2011.2.127-136.SCI |
113. Alfred O.Mueck ,Xiangjan Ruan .Benefits and risks during HRT: main safety issue breast cancer.Horm Mol Biol Clin Invest.2011.5(2).105-116.SCI |
114. 7. Harald Seeger, Xiangjan Ruan, Hans Neubauer and Alfred O. Mueck..Effect of drospirenone on proliferation of human benign and cancerous epithelial breast cells .Horm Mol Biol Clin Invest.2011.6(2).211-214.SCI |
115. Ruan X, Neubauer H, Seeger H, Fehm T..Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.. 4th Asia Pacific (COGI-BCGIP),Abstract Book.2011.国际会议.1036644.SCI |
116. Ruan X, Neubauer H, Seeger H, Fehm G, Cahill MA, Yang Y, Mueck AO.. The effect of progesterone and synthetic progestins on the proliferation of human breast cancer cells expressing a membrane-bound progesterone receptor.. Climacteric.2011.14 (1).65.SCI |
117. Ruan X, Neubauer H, Seeger H, Mueck AO.. Membrane-initiated progestogen effect on the proliferation of human breast cancer cell are dependent on kind of progestogen used..The 15th World congress on controversies in obstetrics, gynecology and infertility, Abstract Book.2011.国际会议.A21.SCI |
118. 梁秀兰,阮祥燕*,蒋辉,王迎.SD大鼠绝经模型建立的研究.医学综述.2010.16(9).1414-1416.核心期刊 |
119. 杨树琳,阮祥燕*.绝经妇女心血管疾病发病风险相关因素的研究进展.医学综述.2010.16(14).2159-2162.核心期刊 |
120. 金凤羽,阮祥燕*,Alfred O.Mueck,杜娟,李扬璐,程姣姣,王虎生.复苏后常温条件下卵巢组织活性与时间关系的初步探究.首都医科大学学报.2009.40(04).544-548.核心期刊 |
121. 王珺,阮祥燕*.静息能量消耗对绝经妇女肥胖影响的研究进展.中国妇产科临床杂志.2009.10(1).71-73.核心期刊 |
122. Ruan Xiangyan,Dai Yujie.Study on Chronic Low-grade Inflammation and Influential Factors of Polycystic Ovary Syndrome.Med Princ Pract.2009.18.118–122.SCI |
123. 梁秀兰,阮祥燕*.子宫内膜增生的内分泌治疗进展.中国处方药.2009.24.65-71. |
124. 阮祥燕,梁秀兰.围绝经期内分泌变化.围绝经期诊治进展(中华医学会继续教育教材).2009.4.14-19. |
125. 马丽灵,阮祥燕*.100例卵巢早衰相关因素的调查分析 .实用妇产科杂志.2009.25(4).212-215.核心期刊 |
126. 王珺,阮祥燕*.女性静息能量消耗与肥胖相关因素.中国组织工程研究与临床康复.2009.13(28).5585-5588.核心期刊 |
127. Ruan Xiangyan,Jin Fengyu,Liu Yulan,Peng Zhouli,and Sun Yuugao.Effect of vibration therapy on bone mineral density in postmenopausal women with osteoporosis.Chinese Med J.2008.121(13).1155-1158.SCI |
128. 代玉洁,阮祥燕*.生活方式干预疗法治疗多囊卵巢综合征.中国实用妇科与产科杂志.2007.5.394-396.核心期刊 |
129. 金凤羽,阮祥燕*.机械振动治疗绝经后女性膝骨性关节炎.中国组织工程研究与临床康复.2007.40.8099-8102.核心期刊 |
130. 翟军,阮祥燕*.二甲双胍治疗多囊卵巢综合征有效性相关因素的探讨.实用妇产科杂志.2007.2.94-97.核心期刊 |
131. 王佳宁,阮祥燕.多囊卵巢综合征患者健康相关生活质量的研究.实用妇产科杂志.2007.23(10).610-613.核心期刊 |
132. 阮祥燕,刘玉兰,彭舟丽,季颖,翟军,陈宝英.激素治疗对绝经妇女子宫肌瘤的影响.实用妇产科杂志.2006.7.410-412.核心期刊 |
133. 苏涛,阮祥燕*.卵巢早衰的治疗进展.中华医学研究.2006.6.21-22.核心期刊 |
134. 金凤羽,阮祥燕*.女性围绝经期抑郁新进展.新乡医学院学报.2006.1.100-102.核心期刊 |